title: Targeting toll-like receptors 4 intracellular domain to prevent ischemic liver disease: an innovative approach or just a futuristic dream?.
authors.affiliation: Critical Care Department, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium The Infectious Disease Division, Memorial Hospital of Rhode Island The Alpert Medical School of Brown University, Providence, RI.
authors.forename: Xavier
authors.initials: X
authors.lastname: Wittebole
authors.forename: Pierre-François
authors.initials: PF
authors.lastname: Laterre
authors.forename: Steven M
authors.initials: SM
authors.lastname: Opal
mesh_terms: D000818:Animals; D008099:Liver / Q000098:blood supply*; D008297:Male; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D015427:Reperfusion Injury / Q000517:prevention & control*; D051197:Toll-Like Receptor 4 / Q000037:antagonists & inhibitors*; D052096:Warm Ischemia
chemical_list: D017472:Receptors, Interleukin-1; D051197:Toll-Like Receptor 4